
|Articles|March 1, 2001
The American Journal of Managed Care
- March 2001
- Volume 7
- Issue 3
Renal Effects of Angiotensin-Converting Enzyme Inhibitors That Result in Cost Savings and Improved Patient Outcomes
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
In Its 50th Year, ESMO Comes to Berlin, a City Transformed
2
Physical Activity, Vaccination May Protect Against Long COVID
3
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
4
Real-World Data Show Preventive Nirsevimab Reduces Infant RSV Hospitalizations
5